Stockscreener 앱 받기
1.32
2.22%
-0.03
시간 외 거래:
1.31
-0.01
-0.76%
전일 마감가:
$1.35
열려 있는:
$1.35
하루 거래량:
2.56M
Relative Volume:
0.81
시가총액:
$996.72M
수익:
$581.12M
순이익/손실:
$-212.92M
주가수익비율:
-4.821
EPS:
-0.2738
순현금흐름:
$-174.22M
1주 성능:
-1.12%
1개월 성능:
-12.00%
6개월 성능:
+6.45%
1년 성능:
+3.94%
1일 변동 폭
$1.32
$1.38
1주일 범위
$1.28
$1.38
52주 변동 폭
$0.9769
$1.73
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.32 | 936.31M | 581.12M | -212.92M | -174.22M | -0.2738 |
TMO
Thermo Fisher Scientific Inc
|
580.02 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
199.98 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
590.00 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
141.34 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
399.70 | 36.45B | 3.77B | 449.25M | 240.68M | 7.8556 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | JP Morgan | Neutral |
| 2025-10-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results - Benzinga
OPKO Health (NASDAQ:OPK) Shares Gap Up Following Strong Earnings - MarketBeat
Why Is OPKO Health (NASDAQ:OPK) Stock Drawing Fresh Market Interest Today? - Kalkine Media
OPK Looks 19.0% Overvalued on GF Value™ - GuruFocus
OPKO Health, Inc. 2026 Q2 10-Q Report: Financial Statements, Risk Factors, and Management Discussion - Minichart
OPK Looks 17.9% Overvalued on GF Value™ - GuruFocus
OPKO Health Q2 2026 Results: Key Pipeline Advances, Rayaldee China Expansion, and Improved Financial Performance – Minichart - Minichart
OPKO Health (NASDAQ:OPK) Shares Rise After Q2 Earnings Exceed Forecasts; Nicoya Agreement Lifts After-Hours Gains - TechStock²
Earnings call transcript: OPKO Health posts smaller Q2 loss, shares rise in 2026 - Investing.com Canada
OPK: Q2 2026 delivered higher revenue, improved margins, and raised full-year guidance amid pipeline advances - TradingView
OPKO Health Q2 Earnings Call Highlights - MarketBeat
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
OPK: Profitability improved and revenue grew in Q2 2026, with guidance raised for the full year - TradingView
OPK Looks 17.0% Overvalued on GF Value™ - GuruFocus
OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
OPKO Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
OPKO Health Q2 EPS beats estimates as sales rise 4.3% to $163.5 million - scanx.trade
OPKO Health (NASDAQ:OPK) Issues Earnings Results - MarketBeat
OPKO HEALTH ($OPK) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
OPKO HEALTH, INC. Q2 2026: Revenue $163.6M, EPS $(0.01) — 10-Q Summary - TradingView
OPKO Health: Q2 Earnings Snapshot - Yahoo Finance
(OPK) OPKO Health, Inc. Expects Q3 Revenue Range $131.0M$142.0M - marketscreener.com
OPKO Health reports Q2 2026 revenue $163.5M, operating loss narrows to $7.0M, net loss $8.4M - TradingView
OPKO Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
OPK: Q2 2026 revenue rose and losses narrowed, with clinical and partnership progress highlighted - TradingView
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results - OPKO Health, Inc.
OPKO Begins Phase 1 Trials in B-Cell Lymphoma, COVID Prevention - Stock Titan
OPKO Health Inc (OPK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OPKO Health Inc (OPK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OPK|OPKO Health Inc|Price:1.330| - TradingKey
OPK|OPKO Health Inc|Price:1.220|Chg%:+0.050 - TradingKey
OPKO Health Inc (OPK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OPKO Health Inc (OPK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
OPKO Health, Inc. Revenue Breakdown – DUS:XCY - TradingView
OPKO Health Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
OPKO Health Inc (OPK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - Zacks Investment Research
OPKO Health to Report Second-Quarter 2026 Financial Results on July 27 and Host Conference Call - Quiver Quantitative
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026 - OPKO Health, Inc.
OPKO Health Sets July 27 Webcast for Results and Guidance - Stock Titan
OPKO Health (OPK) Projected to Announce Earnings on Thursday - MarketBeat
Opko Health sets second-quarter results conference call and webcast - Bitget
OPKO Health stock steadies as investors weigh recent earnings and pipeline progress - Ad-hoc-news.de
OPK4048118 Bond Coupon Profile — Rate & Payments - TradingView
OPKO Health, Inc. (NASDAQ:OPK) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
OPKO Health Q1 2026 Earnings: Narrow Loss Meets Estimates as Company Continues Strategic OverhaulConsensus Miss Rate - dars.gov.et
OPK4020628 Bond Risk Profile - TradingView
OPK4048118 Bond Redemption Profile - TradingView
OPK4020628 Bond Coupon Profile — Rate & Payments - TradingView
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Opko Health Inc 주식 (OPK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 21 '25 |
Buy |
1.33 |
580,000 |
768,807 |
216,706,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
1.13%
0.02%
자본화:
|
볼륨(24시간):